RESEARCHER PROFILE
Jason Rogers (Filmed April 2024)
Postdoctoral Fellow
Menzies Institute for Medical Research,
University of Tasmania
Jason Rogers is a Tasmanian physiotherapist clinician-researcher with a longstanding interest in improving musculoskeletal foot and ankle conditions. He completed his PhD at the Menzies Institute for Medical Research at the University of Tasmania in 2022 investigating the clinical and imaging factors associated with a common foot complaint known as chronic plantar heel pain.
Chronic plantar heel pain, historically known as plantar fasciitis, is common and commonly recalcitrant, yet the optimal treatment for this condition is not clear. The focus of Jason’s postgraduate research is on improving treatment pathways for chronic plantar heel pain. In particular his research has identified that there are many different sub-groups of plantar heel pain that may warrant specific and individualised treatment approaches. For example his research found that up to half of people with this condition have a type of bone bruise or stress response in the heel known as a ‘bone marrow lesion’ (BML). His BALSA trial will test the effectiveness of targeting these lesions with a bone-sensitive treatment known as shockwave therapy, comparing pain and BML size outcomes against a sham shockwave control group.
As well as improving treatment outcomes for this specific and sizeable sub-group of heel pain sufferers, this research will help inform the future of targeted care treatment approaches for plantar heel pain.
-
Electrical stimulation on organic conductors
Professor Gordon Wallace AO is the Founder and Director of the Intelligent Polymer Research Institute (IPRI) at the University of Wollongong and Founding Director of the Australian National Fabrication Facility (ANFF) Materials Node. He was previously the Executive Director of the ARC Centre of Excellence for Electromaterials Science (ACES).
-
Role of metabolic dysfunction in advanced prostate cancer
Dr Gunter was drawn to the area of prostate cancer research and the intersection between chronic metabolic disorders and their emerging relationship to cancer. Her strengths include expertise in the metabolic syndrome, insulin signalling and metabolism, and she has a demonstrated record of successful and productive research projects in metabolic research where she now applies her efforts to understanding the role of metabolic dysfunction in advanced prostate cancer.
-
De-prescribing medications in older adults with dementia
Dr. Daniel Hoyle is a Senior Lecturer in Therapeutics and Pharmacy Practice at the School of Pharmacy and Pharmacology, University of Tasmania. He is also an experienced clinical pharmacist with expertise in medication management in older people. Dr. Hoyle’s research interests focus on improving medicine use in older people with dementia.
